Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 107,700 | 89,000 | 92,200 | 75,800 | 87,700 |
| Receivables | 132,800 | 131,900 | 123,000 | 131,300 | 142,800 |
| Inventories | 138,800 | 161,900 | 163,900 | 165,600 | 163,200 |
| Other current assets | 0 | 73,900 | 72,700 | 66,500 | 64,500 |
| TOTAL | $393,400 | $472,600 | $474,100 | $467,800 | $487,000 |
| Non-Current Assets | |||||
| PPE Net | 110,700 | 109,500 | 110,700 | 116,200 | 117,200 |
| Intangibles | 567,900 | 1,015,200 | 1,020,600 | 1,027,700 | 1,035,600 |
| Other Non-Current Assets | 82,200 | 58,900 | 52,400 | 49,600 | 52,600 |
| TOTAL | $760,800 | $1,183,600 | $1,183,700 | $1,193,500 | $1,205,400 |
| Total Assets | $1,154,200 | $1,656,200 | $1,657,800 | $1,661,300 | $1,692,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,400 | 9,400 | 10,200 | 9,400 | 8,600 |
| Accounts payable and accrued liabilities | 54,300 | 54,200 | 51,400 | 57,000 | 56,300 |
| Accrued Expenses | 91,300 | 82,700 | 79,500 | 75,100 | 93,200 |
| Other current liabilities | N/A | 52,900 | 52,700 | 52,200 | 63,700 |
| TOTAL | $165,900 | $212,900 | $208,200 | $205,200 | $234,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 125,300 | 152,600 | 164,900 | 167,200 | 159,400 |
| Other Non-Current Liabilities | 29,000 | 37,100 | 39,300 | 37,400 | 38,300 |
| TOTAL | $159,800 | $213,600 | $227,600 | $228,200 | $221,500 |
| Total Liabilities | $325,700 | $426,500 | $435,800 | $433,400 | $456,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,003 | 45,957 | 45,949 | 45,904 | 46,203 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | -707,000 | -309,700 | -314,000 | -315,800 | -314,900 |
| Other shareholders' equity | -44,600 | -36,800 | -37,000 | -29,500 | -26,900 |
| TOTAL | $828,500 | $1,229,700 | $1,222,000 | $1,227,900 | $1,236,300 |
| Total Liabilities And Equity | $1,154,200 | $1,656,200 | $1,657,800 | $1,661,300 | $1,692,400 |